Symmetry Peak Management LLC Catalyst Pharmaceuticals, Inc. Transaction History
Symmetry Peak Management LLC
- $177 Million
- Q2 2025
A detailed history of Symmetry Peak Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Symmetry Peak Management LLC holds 15,000 shares of CPRX stock, worth $307,950. This represents 0.14% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$307,950% of portfolio
0.14%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
386Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$384 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$180 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$112 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.8 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$65.4 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.11B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...